P2857Increase in pulse rate with semaglutide did not result in increased adverse cardiac events in subjects with type 2 diabetes in the SUSTAIN 6 cardiovascular outcomes trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.